FDA Releases Pregnancy Safety Guidance for Drugs and Biologics
WASHINGTON, D.C., United States – May 8, 2026 The U.S. Food and Drug Administration announced the release of a...
Pharmacovigilance
Advertisement
Persistent Strengthens Life Sciences AI Through Databricks
SANTA CLARA, Calif. and PUNE, India , May 7, 2026 Persistent Systems announced it has achieved the Databricks Brickbuilder...
Keenova TERLIVAZ Real-World Data Advances HRS-AKI Care
Dublin, Ireland | May 1, 2026 Keenova Therapeutics has announced new real-world clinical analysis of TERLIVAZ® (terlipressin) for hepatorenal...
EMA Recommends First RNA-Based Veterinary Vaccine in EU
AMSTERDAM, Netherlands, April 17, 2026 The European Medicines Agency (EMA), through its Committee for Veterinary Medicinal Products (CVMP), has...
GlycoNex Secures PMDA Nod for GNX1021 Phase 1 Trial
NEW TAIPEI CITY, TAIWAN, April 14, 2026 GlycoNex, Inc. has received approval from Japan’s Pharmaceuticals and Medical Devices Agency...
Advertisements
Revolution Medicines Reports Phase 3 Survival Gain PDAC
REDWOOD CITY, CALIFORNIA, USA, April 13, 2026 Revolution Medicines has announced positive topline results from its pivotal Phase 3...
Neurocrine Shows INGREZZA Persistence Edge in TD Study
SAN DIEGO, USA, April 14, 2026 Neurocrine Biosciences has presented new real-world evidence (RWE) demonstrating that patients treated with...
Amlodipine Recall Issued Over Wrong Drug Risk
Ottawa, Canada — February 6, 2026 Health authorities have issued a public advisory announcing the recall of two lots...
MIPLYFFA Real-World Data Strengthen NPC Treatment Impact
CELEBRATION, Fla., Feb. 4, 2026 —Zevra Therapeutics announced the presentation of positive new real-world data on MIPLYFFA® (arimoclomol) in...
Advertisement
